TRIGLYTZA® VERSUS METFORMIN IN OBESE ADULT TYPE 2 DIABETES (T2DM) PATIENTS OVER 24 WEEKS OF TREATMENT

NCT07139405 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes (T2DM)

Interventions

DRUG: Metformin XR 1000mg
DRUG: Valsartan 80mg Tablet
DRUG: Valsartan 160mg tablet
DRUG: Celecoxib (Celebrex®) 100mg
DRUG: Celecoxib (Celebrex®) 200mg
DRUG: Metformin XR 500 mg

Sponsor

Myopharm Limited